The larger attachment glycoprotein of respiratory syncytial virus produced in primary human bronchial epithelial cultures reduces infectivity for cell lines.
Respiratory syncytial virus (RSV) infects the upper and lower respiratory tracts and can cause lower respiratory tract infections in children and elders. RSV has traditionally been isolated, grown, studied and quantified in immortalized cell lines, most frequently HEp-2 cells. However, in vivo RSV i...
Guardado en:
Autores principales: | Tiffany King, Asuncion Mejias, Octavio Ramilo, Mark E Peeples |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a3d5bf5276134086b1d24e01dc056af9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Roflumilast inhibits respiratory syncytial virus infection in human differentiated bronchial epithelial cells.
por: Manuel Mata, et al.
Publicado: (2013) -
Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants
por: Asunción Mejías, et al.
Publicado: (2008) -
Whole blood gene expression profiles to assess pathogenesis and disease severity in infants with respiratory syncytial virus infection.
por: Asuncion Mejias, et al.
Publicado: (2013) -
Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein
por: Daiyin Tian, et al.
Publicado: (2017) -
Role of CCR3 in respiratory syncytial virus infection of airway epithelial cells
por: Vincent Wellemans, et al.
Publicado: (2021)